C-reactive protein and hypertension.

Area of Science:

• Cardiovascular Medicine
• Inflammation Biology
• Hypertension Research

Background:

• C-reactive protein (CRP) is a well-established biomarker for cardiovascular disease (CVD).
• CRP levels are used to assess cardiovascular risk and guide therapy selection in intermediate-risk individuals.
• The role of CRP in hypertension is increasingly recognized.

Purpose of the Study:

• To review the multifaceted role of C-reactive protein (CRP) in the context of hypertension.
• To explore CRP's association with hypertension-related vascular damage and cardiovascular outcomes.
• To examine CRP's potential as a predictor of hypertension development and its direct role in vascular pathology.

Main Methods:

• Review of existing literature on C-reactive protein (CRP) and hypertension.
• Analysis of studies investigating CRP levels in hypertensive and normotensive individuals.
• Examination of experimental data on CRP's direct effects on vascular function and remodeling.

Main Results:

• In hypertensive individuals, CRP levels correlate with vascular stiffness, atherosclerosis, end-organ damage, and cardiovascular events.
• Some antihypertensive drugs may reduce CRP levels independently of blood pressure effects.
• Baseline CRP levels predict future hypertension development in normotensive individuals.
• CRP actively contributes to endothelial dysfunction, vascular stiffness, and elevated blood pressure.
• CRP is implicated in vascular and cardiac remodeling processes.

Conclusions:

• C-reactive protein (CRP) is a significant biomarker and active participant in hypertension pathogenesis.
• CRP's role extends beyond risk prediction to direct mediation of vascular dysfunction and remodeling.
• Further research into CRP-mediated inflammatory pathways may reveal novel therapeutic targets for hypertension and related vascular diseases.